F&P Optiflow Junior 2+ Handbuch Seite 2

Apply Remove
I II
Cannula Cannula
1 2
3
4
3
III Replace
F&P Wigglepads 2
™
1
2
4
F&P Optiflow Junior 2+ nasal cannula
™
GENERAL CAUTIONS
Intended Use
• Regularly monitor the patient to ensure skin
integrity and that the skin underneath the cannula
The Fisher & Paykel Healthcare Optiflow Junior 2+
remains dry. A barrier film may be
nasal cannula is a single use nasal cannula
used between the cannula and the patient's upper
intended for use with a nasal high flow therapy
lip to prevent irritation.
system to deliver heated and humidified nasal
high flow therapy to spontaneously breathing • DO NOT soak, sterilize, or reuse this product. Avoid
patients who require breathing support. contact with chemicals, cleaning agents, or hand
sanitizers. Secretions on the cannula and the
This product is designed for use in hospital
environments and must be prescribed by a prongs can be removed by gently wiping with a
damp cloth.
physician.
• Reuse may result in the transmission of infectious
The F&P Optiflow Junior 2+ nasal cannula is
substances, interruption to treatment, serious harm
intended for use in infants and children greater
or death.
than 8 kg.
• DO NOT stretch the cannula on application; this
General Warnings
may cause increased pressure to the patient's skin.
If necessary, the cannula may be repositioned.
• This product is only designed and verified • Tubing may pose a risk of strangulation or airway
for use with equipment, accessories and restriction.
spare parts approved by F&P. Unauthorized
• DO NOT use if the product or its packaging
equipment, accessories or spare parts
has been tampered with.
which are used with this product may impair
• Ensure the patient does not lie on the tubing
performance of this product or compromise
as this may apply pressure to the patient's
safety (including potentially causing serious
ears or face.
patient harm).
• Product to only be used with medical grade gas
• Appropriate patient monitoring (e.g. oxygen supplies. The gas supply used with this device may
saturation) must be used at all times.
unexpectedly fail to deliver oxygen or flow.
Failure to monitor the patient (e.g. in the
• Failure to apply and use this product within the
event of an interruption to gas flow) may
directions, transport, storage and operating
result in serious harm or death.
conditions specified in the labeling and user
• If using supplemental oxygen, keep ignition instructions may impair performance of this
sources away from the patient. product or compromise safety (including
potentially causing serious patient harm).
5
ENGLISH
Optiflow™, Wigglepads™, and the Dolphin image shown in this user instruction are trade marks of
Fisher & Paykel Healthcare Limited.
© 2019 Fisher & Paykel Healthcare Limited.
For patent information, see www.fphcare.com/ip
California residents please be advised of the following, pursuant to Proposition 65:
WARNING
This product contains chemicals known to the State of California to cause cancer, birth defects and other
reproductive harm.
For more information, please visit: www.fphcare.com/prop65
ENGLISH
10